Skip to main content
Journal ArticleOPEN ACCESS

Teriflunomide for relapsing remitting multiple sclerosis

  • Chaplin S
  • Schmierer K
Prescriber (2015) 26(18) 11-14
DOI: 10.1002/psb.1384
N/ACitations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Teriflunomide (Aubagio) is licensed for the treatment of adults with RRMS. Here, Steve Chaplin presents the clinical data relating to its efficacy and Dr Schmierer discusses its place in therapy.

Cite

CITATION STYLE

APA

Chaplin, S., & Schmierer, K. (2015). Teriflunomide for relapsing remitting multiple sclerosis. Prescriber, 26(18), 11–14. https://doi.org/10.1002/psb.1384

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free